BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25351530)

  • 21. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
    Wang LQ; Sun W; Wang Y; Li D; Hu AM
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Speckle-Type POZ Protein Promotes Prostate Cancer Cell Migration and Invasion Through Upregulation of MCP-1.
    Shi J; Cao J; Lu X; Fan L; Guo H; Fu J
    Med Sci Monit; 2021 Apr; 27():e929199. PubMed ID: 33872295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma.
    Cheng MW; Wang BC; Weng ZQ; Zhu XW
    Acta Histochem; 2012 Sep; 114(5):503-9. PubMed ID: 22000864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer.
    Zeng C; Wang Y; Lu Q; Chen J; Zhang J; Liu T; Lv N; Luo S
    J Exp Clin Cancer Res; 2014 Sep; 33(1):75. PubMed ID: 25204354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-16-1 plays a role in reducing migration and invasion of glioma cells.
    Li X; Ling N; Bai Y; Dong W; Hui GZ; Liu D; Zhao J; Hu J
    Anat Rec (Hoboken); 2013 Mar; 296(3):427-32. PubMed ID: 23175429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
    Bao Z; Feng Y; Wang H; Zhang C; Sun L; Yan Z; Liu Q; Guo T; Li M; Yang X; Jiang C; Zhang Q; Jiang T
    Oncol Rep; 2014 Jul; 32(1):250-60. PubMed ID: 24842301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma.
    Tian X; Zhang L; Sun L; Xue Y; Xie S
    J Int Med Res; 2014 Jun; 42(3):651-8. PubMed ID: 24743871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.
    Huang Y; Tan N; Jia D; Jing Y; Wang Q; Li Z; Zhang J; Liu L; Li J; Chen Z; He X
    Tumour Biol; 2015 Dec; 36(12):9753-61. PubMed ID: 26156804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas.
    Chen YH; Hueng DY; Tsai WC
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR125a-5p acting as a novel Gab2 suppressor inhibits invasion of glioma.
    Sun L; Zhang B; Liu Y; Shi L; Li H; Lu S
    Mol Carcinog; 2016 Jan; 55(1):40-51. PubMed ID: 25598421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
    Genkai N; Homma J; Sano M; Tanaka R; Yamanaka R
    Oncol Rep; 2006 Jun; 15(6):1569-74. PubMed ID: 16685397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
    Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
    Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of CPEB4 in glioma indicates a poor prognosis by promoting cell migration and invasion.
    Zhijun L; Dapeng W; Hong J; Guicong W; Bingjian Y; Honglin L
    Tumour Biol; 2017 Apr; 39(4):1010428317694538. PubMed ID: 28381179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.
    Xu Y; Yuan J; Zhang Z; Lin L; Xu S
    Mol Biol Rep; 2012 Sep; 39(9):8979-85. PubMed ID: 22714920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
    Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
    Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Speckle-type POZ protein up-regulates c-Jun protein expression and promotes proliferation and invasion of renal carcinoma cells].
    Wu L; Yu K; Cue Y; Zhu X; Yang Z; Ma J
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):447-452. PubMed ID: 33849838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
    Wang Q; Zhang J; Liu Y; Zhang W; Zhou J; Duan R; Pu P; Kang C; Han L
    Cancer Lett; 2016 Apr; 373(2):251-9. PubMed ID: 26828136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome.
    Lu S; Niu N; Guo H; Tang J; Guo W; Liu Z; Shi L; Sun T; Zhou F; Li H; Zhang J; Zhang B
    Eur J Cancer; 2013 Feb; 49(3):752-63. PubMed ID: 23063350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.